Propofol Injection, Emulsion
Product Images NDC 80830-2365

10 FDA label images from Amneal Pharmaceuticals Private Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 80830-2365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Propofol Injectable Emulsion Usp 1)

1 (Propofol Injectable Emulsion Usp 1)
Chemical structure diagram of propofol, showing a benzene ring with three substituents: two isopropyl groups and one hydroxyl group, consistent with the compound's molecular configuration.*
FDA Label Image

1 (Propofol Injectable Emulsion Usp 2)

1 (Propofol Injectable Emulsion Usp 2)
A line graph illustrating plasma propofol concentration (mcg/mL) over time (minutes) after the end of infusion at different infusion durations: 10 day, 10 hour, and 1 hour. The graph shows how plasma levels decrease post-infusion, with an indicated target plasma concentration and a marked awakening point.*
FDA Label Image

1 (Propofol Injectable Emulsion Usp 3)

1 (Propofol Injectable Emulsion Usp 3)
Label for Propofol Injectable Emulsion, USP 10 mg/mL (200 mg per 20 mL) by Amneal Pharmaceuticals Private Limited. The label indicates it is for intravenous use, single patient use only, and instructs to shake well before using. It lists inactive ingredients including soybean oil and glycerol, with storage instructions and a barcode present.*
FDA Label Image

2 (Propofol Injectable Emulsion Usp 4)

2 (Propofol Injectable Emulsion Usp 4)
Carton packaging label for PROPOFOL Injectable Emulsion USP 200 mg per 20 mL (10 mg/mL) intravenous injection emulsion. The label includes manufacturer information for Amneal Pharmaceuticals Pvt. Ltd. in India, distributor as Amneal Pharmaceuticals LLC in New Jersey, and details on storage and handling. It warns to use strict aseptic technique and notes the product contains EDTA to inhibit microbial growth for up to 12 hours after opening.*
FDA Label Image

1 (Propofol Injectable Emulsion Usp 5)

1 (Propofol Injectable Emulsion Usp 5)
Label for Propofol Injectable Emulsion, USP 10 mg/mL (500 mg per 50 mL), for intravenous administration. The label states the product is sterile, nonpyrogenic, and contains propofol along with soybean oil, glycerol, egg phospholipids, and other ingredients. It advises strict aseptic technique and discarding within 12 hours after opening due to EDTA content. The product is distributed by Amneal Pharmaceuticals LLC, made in India, and includes storage instructions (store between 4° to 25°C).*
FDA Label Image

2 (Propofol Injectable Emulsion Usp 6)

2 (Propofol Injectable Emulsion Usp 6)
Box packaging label for PROPOFOL Injectable Emulsion, USP injection emulsion, with 500 mg per 50 mL (10 mg/mL) strength. It is labeled for intravenous administration and instructs to shake well before use. The label notes the presence of EDTA to inhibit microbial growth and advises use within 12 hours of opening. Manufactured by Amneal Pharmaceuticals Private Limited, the package holds 20 vials of 50 mL each for single patient use.*
FDA Label Image

3 (Propofol Injectable Emulsion Usp 7)

3 (Propofol Injectable Emulsion Usp 7)
Label for Propofol Injectable Emulsion, USP, 10 mg/mL (1,000 mg per 100 mL) for intravenous administration. The label includes instructions to shake well before use, store between 4° to 25°C, and use aseptic technique. It notes that the emulsion contains EDTA which inhibits microbial growth for up to 12 hours once opened. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*
FDA Label Image

4 (Propofol Injectable Emulsion Usp 8)

4 (Propofol Injectable Emulsion Usp 8)
Carton label for PROPOFOL Injectable Emulsion, USP 10 mg/mL (1,000 mg per 100 mL) for intravenous administration. The label includes instructions to shake well before use and warnings about aseptic technique and EDTA use. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. Package contains 10 x 100 mL single-patient-use vials.*
FDA Label Image

5 (Propofol Injectable Emulsion Usp 9)

5 (Propofol Injectable Emulsion Usp 9)
Label for PROPOFOL Injectable Emulsion, USP, 10 mg/mL (equivalent to 1000 mg per 100 mL) intravenous injection. The label states it is sterile and nonpyrogenic. It includes warnings to use strict aseptic technique, contains EDTA to inhibit microbial growth, and instructions to shake well before use. Manufactured by Amneal Pharmaceuticals Private Limited and distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label also includes storage instructions to keep between 4° to 25°C and not to freeze.*
FDA Label Image

6 (Propofol Injectable Emulsion Usp 10)

6 (Propofol Injectable Emulsion Usp 10)
Label for Propofol Injectable Emulsion, USP 10 mg/mL (1,000 mg per 100 mL) by Amneal Pharmaceuticals Private Limited. This injection emulsion is for intravenous use, provided in 10 x 100 mL vials, with instructions to shake well before using. The label includes warnings about using aseptic technique and the presence of EDTA to inhibit microbial growth for up to 12 hours after opening.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.